Inka Berglar
6 Papers
Inka Berglar is an academic researcher. The author has contributed to research in topics: Medicine & Phenotype. The author has co-authored 2 publications.
Chat about Author
Papers
Real-World Performance of Large Vessel Occlusion CADt AI Algorithms - What the Stroke Team needs to know.
M. M. Kunst,Rajiv Gupta,Laura Coombs,Jana G. Delfino,Inka Berglar,Juan E. Small,Laura B Gillis,Patrick Noonan,Mike Tilkin,Bibb Allen,Keith P. Dreyer,Christoph Wald +11 more
TL;DR: In this paper , the authors evaluate the real-world performance of two FDA-approved artificial intelligence (AI)-based computer-aided triage and notification (CADt) detection devices and compare them with the manufacturer-reported performance testing in the instructions for use.
12
CHRDL1 Regulates Stemness in Glioma Stem-like Cells
Inka Berglar,Stephanie Hehlgans,Andrej Wehle,Caterina Roth,Christel Herold-Mende,Franz Rödel,Donat Kögel,Benedikt Linder +7 more
TL;DR: In this paper , it has been shown that CHRDL1 antagonizes the function of bone morphogenic protein 4 (BMP4), which induces GSC differentiation and, hence, reduces tumorigenicity.
Radical surgical resection with molecular margins is associated with improved survival in IDH wildtype GBM.
Elie Massaad,William J Smith,Joseph Bradley,Eric Esposito,Mihir Gupta,Evan J. Burns,Ryan Burns,José K Velarde,Inka Berglar,Rajiv Gupta,M. Martinez-Lage,J. Dietrich,Jochen K Lennerz,Gavin P Dunn,Pamela S. Jones,Bryan D Choi,Albert H. Kim,Matthew Frosch,Fred G Barker,William T. Curry,Bob S. Carter,Brian V. Nahed,Daniel P Cahill,Ganesh M. Shankar +23 more
TL;DR: These findings identify a subset of patients with glioblastoma IDH wild-type GBM that may derive local control benefit from radical resection to undetectable molecular margins.
3
The Impact of Dual Antiplatelet Therapy Duration on Unruptured Aneurysm Occlusion After Flow Diversion: A Multicenter Study
Justin E Vranic,Pablo Harker,Christopher J Stapleton,Robert W. Regenhardt,Adam A Dmytriw,Omer Doron,Naif M. Alotaibi,Thabele M Leslie-Mazwi,Rajiv Gupta,Inka Berglar,Can Ozan Tan,Matthew J. Koch,Scott B. Raymond,Justin R Mascitelli,Thomas Tyler Patterson,Joshua Seinfeld,A. White,David Case,Christopher Roark,Chirag D. Gandhi,Fawaz Al-Mufti,Jared B. Cooper,Charles C. Matouk,Nanthiya Sujijantarat,Diego Devia,Maria Isabel Ocampo-Navia,Daniel E. Villamizar‐Torres,Juan Carlos Puentes,Aman B. Patel +28 more
TL;DR: After flow diversion, an abbreviated duration of DAPT lasting 6 months may be most appropriate before transitioning to low-dose aspirin monotherapy to promote timely aneurysm occlusion while minimizing thromboembolic complications.
2
The Impact of Preprocedural Platelet Function Testing on Periprocedural Complication Rates Associated With Pipeline Flow Diversion: An International Multicenter Study.
Justin E Vranic,Adam A Dmytriw,Inka Berglar,Naif M. Alotaibi,Nicole M. Cancelliere,Christopher J Stapleton,James D. Rabinov,Pablo Harker,Rajiv Gupta,Joshua D Bernstock,Matthew J Koch,Scott B Raymond,Justin R Mascitelli,Thomas Tyler Patterson,Joshua Seinfeld,A. White,David Case,Christopher Roark,Chirag D. Gandhi,Fawaz Al-Mufti,Jared Cooper,Charles C. Matouk,Nanthiya Sujijantarat,Diego Devia,Maria Isabel Ocampo-Navia,Daniel E. Villamizar‐Torres,Juan Carlos Puentes,Mohamed M Salem,Ammad Anwar Baig,K. El Namaani,A. Kühn,Bryan Pukenas,Brian T. Jankowitz,J. Burkhardt,Adnan Siddiqui,P. Jabbour,Ajit S. Puri,Robert W. Regenhardt,Vitor Mendes Pereira +38 more
TL;DR: Preprocedural PFT before PED treatment of intracranial aneurysms in patients premedicated with an aspirin and clopidogrel DAPT regimen may not be necessary to significantly reduce the risk of procedure-related intracranial complications.
1